Revascularization in patients with chronic ischaemic myocardial dysfunction: Insights from cardiovascular magnetic resonance imaging

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 12, 2012, Pages 985-990

  Bondarenko, Olga ^a   Beek, Aernout M ^a   McCann, Gerry P ^b   Van Rossum, Albert C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance imaging; Myocardial viability

Indexed keywords

DOBUTAMINE; GADOLINIUM;

ARTERIAL WALL THICKNESS; CARDIOVASCULAR MAGNETIC RESONANCE; EXERCISE TEST; HEART EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; KIDNEY FAILURE; MYOCARDIAL HIBERNATION; NEPHROGENIC SYSTEMIC FIBROSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

CARDIOMYOPATHIES; CHRONIC DISEASE; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RECOVERY OF FUNCTION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84869381746     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes194     Document Type: Review

References (43)

1. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
2. Camici PG, Wijns W, Borgers M et al. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation 1997;96:3205-14. (Pubitemid 27500127)
3. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
4. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002. (Pubitemid 29529292)
5. Bondarenko O, Beek AM, Nijveldt R, McCann GP, van Dockum WG, Hofman MB et al. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis. J Cardiovasc Magn Reson 2007;9:815-21. (Pubitemid 47463906)
6. Bondarenko O, Beek AM, Twisk JW, Visser CA, van Rossum AC. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. Eur Heart J 2008;29: 2000-5.
7. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
8. Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004; 110:1535-41. (Pubitemid 39297973)
9. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172-4. (Pubitemid 38625392)
10. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998;31:1040-8. (Pubitemid 28212504)
11. Cwajg JM, Cwajg E, Nagueh SF, He ZX, Qureshi U, Olmos LI et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000;35:1152-61. (Pubitemid 30206889)
12. Beek AM, van Rossum AC. Use of cardiovascular magnetic resonance imaging in the assessment of left ventricular function, scar and viability in patients with ischaemic cardiomyopathy and chronic myocardial infarction. Heart 2010;96: 1494-501.
13. Kim RJ, Shah DJ. Fundamental concepts in myocardial viability assessment revisited: when knowing how much is 'alive' is not enough. Heart 2004;90:137-40. (Pubitemid 38147140)
14. Dendale P, Franken PR, Holman E, Avenarius J, van der Wall EE, de Roos A. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol 1998;82:375-7. (Pubitemid 28364256)
15. Baer FM, Theissen P, Crnac J, Schmidt M, Deutsch HJ, Sechtem U et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000;21:981-91. (Pubitemid 30312087)
16. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:147-86.
17. Bondarenko O, Beek AM, Hofman MB, Kuhl HP, Twisk JW, van Dockum WG et al. Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-5. (Pubitemid 40563339)
18. Heiberg E, Ugander M, Engblom H, Gotberg M, Olivecrona GK, Erlinge D et al. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 2008;246: 581-8.
19. Hsu LY, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI. Part I: animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23:298-308. (Pubitemid 43364055)
20. Beek AM, Bondarenko O, Afsharzada F, van Rossum AC. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Reson 2009;11:6.
21. Graziani G, Montanelli A, Brambilla S, Balzarini L. Nephrogenic systemic fibrosis an unsolved riddle. J Nephrol 2009;22:203-7.
22. Morcos SK. Nephrogenic systemic fibrosis following the administration of extracellular gadolinium based contrast agents: is the stability of the contrast agent molecule an important factor in the pathogenesis of this condition? Br J Radiol 2007;80:73-6. (Pubitemid 46951248)
23. Forleo GB, Santini L, Della Rocca DG, Romano V, Papavasileiou LP, Magliano G et al. Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dualchamber implant outcomes. Heart Rhythm 2010;7:750-4.
24. Bove CM, DiMaria JM, Voros S, Conaway MR, Kramer CM. Dobutamine response and myocardial infarct transmurality: functional improvement after coronary artery bypass grafting-initial experience. Radiology 2006;240:835-41. (Pubitemid 44267342)
25. Knuesel PR, Nanz D, Wyss C, Buechi M, Kaufmann PA, von Schulthess GK et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 2003;108:1095-100. (Pubitemid 37071520)
26. Kirschbaum SW, Rossi A, van Domburg RT, Gruszczynska K, Krestin GP, Serruys PW et al. Contractile reserve in segments with nontransmural infarction in chronic dysfunctional myocardium using low-dose dobutamine CMR. JACC Cardiovasc Imaging 2010;3:614-22.
27. FlamengW, Suy R, Schwarz F, Borgers M, Piessens J, Thone F et al. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy postrevascularization surgery. Am Heart J 1981;102:846-57. (Pubitemid 11027152)
28. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45. (Pubitemid 24242739)
29. Vanoverschelde JL, Depre C, Gerber BL, Borgers M, Wijns W, Robert A et al. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol 2000; 85:1432-9. (Pubitemid 30336578)
30. Selvanayagam JB, Jerosch-Herold M, Porto I, Sheridan D, Cheng AS, Petersen SE et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation 2005;112: 3289-96. (Pubitemid 43739374)
31. Bax JJ, Maddahi J, Poldermans D, Elhendy A, Cornel JH, Boersma E et al. Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med 2002;43:795-802. (Pubitemid 34663302)
32. Pagano D, Bonser RS, Townend JN, Ordoubadi F, Lorenzoni R, Camici PG. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998;79:281-8. (Pubitemid 28212218)
33. Pegg TJ, Selvanayagam JB, Jennifer J, Francis JM, Karamitsos TD, Dall'Armellina E et al. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12:56.
34. Bax JJ, Schinkel AF, Boersma E, Elhendy A, Rizzello V, Maat A et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse longterm prognosis. Circulation 2004;110(11 Suppl. 1):II18-22. (Pubitemid 39263692)
35. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501-55.
36. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-16.
37. Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-25.
38. Messroghli DR, Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP et al. Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58:34-40. (Pubitemid 47229915)
39. Gutberlet M, Frohlich M, Mehl S, Amthauer H, Hausmann H, Meyer R et al. Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization. Eur Radiol 2005;15:872-80. (Pubitemid 41166718)
40. Gunning MG, Anagnostopoulos C, Knight CJ, Pepper J, Burman ED, Davies G et al. Comparison of 201Tl, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998;98: 1869-74. (Pubitemid 28509282)
41. Baks T, van Geuns RJ, Duncker DJ, Cademartiri F, Mollet NR, Krestin GP et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol 2006;47:721-5. (Pubitemid 43243092)
42. Kuhl HP, Lipke CS, Krombach GA, Katoh M, Battenberg TF, Nowak B et al. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006;27:846-53.
43. Wu YW, Tadamura E, Yamamuro M, Kanao S, Marui A, Tanabara K et al. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med 2007;48: 1096-103. (Pubitemid 47052649)